Skip to main content

Towards evidence‐based use of serum tumour marker requests: an audit of use in a tertiary hospital

Buy Article:

$43.00 plus tax (Refund Policy)

Background : Serum tumour markers (TM) are often measured in hospital patients. The reasons for their use and their benefits with regards to earlier cancer diag­nosis and patient management are not known.
No References
No Citations
No Supplementary Data
No Data/Media
No Metrics

Keywords: AFP; CA 15‐3; CA 19‐9; CA‐124; CEA; guidelines; tumour markers

Document Type: Research Article

Affiliations: 1: Department of Medical Oncology and Haematology, Peter MacCallum Cancer Centre, and Departments of 2: Medical Oncology and 3: Biochemistry, Alfred Hospital, Melbourne, Victoria, Australia

Publication date: 2004-09-01

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more